PLX — PROTALIX BIOTHERAPEUTICS INC

Ownership history in Diametric Capital, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Diametric Capital, LP reported a position in PROTALIX BIOTHERAPEUTICS INC (PLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.15% (2025 Q3)
Avg. % of fund
0.11%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 138,929 -41,055 -22.8% 0.07% $250K $1.80
2025 Q3 ADDED 179,984 +36,712 +25.6% 0.15% $400K $2.22
2025 Q2 INITIATED 143,272 — — 0.11% $212K $1.48
% of Fund (quarterly)    PLX price (monthly, adj. close)

Other funds also holding PLX

As of 2025 Q4 — sorted by position size

Opaleye Management Inc. 3Y 7Y 0.59% Orin Green Financial, LLC 3Y 0.04% Round Rock Advisors LLC 3Y 0.04% Main Street Financial Solutions, LLC 3Y 0.03% Stratos Wealth Partners, LTD. 3Y 7Y 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.01% HARBOUR INVESTMENT MANAGEMENT LLC 3Y 7Y 0.01% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01% EVERGREEN CAPITAL MANAGEMENT LLC 3Y 7Y 0.01% EARNED WEALTH ADVISORS, LLC 3Y 0.0%
← Back to Diametric Capital, LP Holdings